Movies Published 20 hours ago Last Update 19 hours

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
158
Movies
Published 20 hours ago
Last Update 19 hours ago
'The Hunt' canceled by Universal following significant backlash
< >

Universal Pictures has canceled the September 27 release of the controversial movie "The Hunt," in the wake of significant backlash over the film that depicts privileged vacationers hunting "deplorables" for sport.

NBC’s Universal Pictures, which shares parent company Comcast with NBC News and MSNBC, told Fox News on Wednesday that the movie’s marketing campaign would be “temporarily paused” on the heels of the tragic mass shootings in El Paso, Texas, Dayton, Ohio, and Gilroy, California.

At that time, it had no plans to shelf the movie itself.

HOLLYWOOD BLOCKBUSTER THAT SATIRIZES KILLING OF ‘DEPLORABLES’ CAUSES OUTRAGE: ‘DEMENTED AND EVIL’

But in a statement released to Fox News on Saturday, a Universal Pictures spokesperson said: “While Universal Pictures had already paused the marketing campaign for The Hunt, after thoughtful consideration, the studio has decided to cancel our plans to release the film.

“We stand by our filmmakers and will continue to distribute films in partnership with bold and visionary creators, like those associated with this satirical social thriller, but we understand that now is not the right time to release this film.”

According to a source, “Universal insiders feel that doing the right thing was more important than releasing the movie because of the current climate.”

There are no official plans for the future of "The Hunt." It could still be released at a later date or move to a streaming service.

The movie featured Betty Gilpin and Oscar-winner Hilary Swank, was written by Nick Cuse and Damon Lindelof and directed by Craig Zobel.

It was billed as a satirical take on wealthy liberal thrill-seekers taking a private jet to a five-star resort where they embark on a “deeply rewarding” expedition that involves hunting down and killing designated humans.

COMCAST’S NBC UNIVERSAL LABELED ‘PATENTLY HYPOCRITICAL’ OVER PUSHING BOTH 'THE HUNT' AND GUN CONTROL

Those designated humans being “MAGA types" as described by The Hollywood Reporter. “Nothing better than going out to the Manor and slaughtering a dozen deplorables," a character says, according to THR.

The term was originally coined by Hillary CIinton during the 2016 election as a derogatory reference to Trump supporters. The movie was reportedly going to be called, "Red State vs. Blue State," at first.

Variety reported on Saturday morning that Swank said she wouldn't discuss the film while at the Locarno Film Festival in Switzerland. “No one’s seen the film. You can’t really have a conversation about it without understanding what it’s about," she said.

On Friday, President Trump slammed Hollywood and presumably the movie.

“Hollywood, I don’t call them the elites. I think the elites are the people they go after in many cases. But Hollywood is really terrible,” he said.

“What they’re doing, with the kind of movie they’re putting out, it’s actually very dangerous for our country. What Hollywood is doing is a tremendous disservice to our country.”
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Habitat for Humanity AZ's Unique Gala: An Overview

Updated Category News Views 56

Mark Your Calendars: A Night to Celebrate Listen up, Central Arizona, because I'm giving you the lowdown on Habitat for Humanity Central Arizona's big night out. "Blueprints & Blue Jeans" - it's the gala that's ditching the formalities for some good old-fashioned community fun, but with a seriously important mission at its heart. Mark your calendars for Friday, March 5,...

Continue Reading
Radiation Oncology Text Earns Doody's 2026 Nod

Updated Category News Views 122

Recognition in Radiation Oncology In the rapidly advancing arena of radiation oncology, staying current is no small feat. But here's a feather in the cap of one publication doing just that: Fundamentals of Radiation Oncology: Physical, Biological, and Clinical Aspects, 4th Edition. This resource has made quite the splash by snagging a spot on the 2026 Doody's Core Titles...

Continue Reading
Blue Owl Tech Faces Lawsuit Post-44% Share Dive

Updated Category News Views 59

The air's thick with tension for investors of Blue Owl Technology Finance Corp. (NYSE:OTF) as they wake up to the news of a securities class action lawsuit that's no small fry. You don’t have to look too far to see why the folks holding the bag might be steamed. We’re talking about a 44% drop in stock price since the merger with Blue Owl Technology Finance Corp....

Continue Reading
TELUS Targets Debt Reduction Amid Telecom Transformation

Updated Category News Views 99

Adjusting Strategy Amid Financial Challenges The market's a tough beast, and TELUS seems to be wrestling with it, showing both grit and foresight in its latest quarterly update. Third quarter 2026 has TELUS down on revenues with a notable net loss but don't count them out yet. Their Transformation Strategy is a gamble worth watching. Where the Numbers Stand Here's the...

Continue Reading
Havertys Dividend: A Steady Payout Tradition Continues

Updated Category News Views 87

Another Year, Another Dividend for Havertys Man, talk about a company with a rock-solid habit. Havertys Furniture Companies (NYSE: HVT) just announced its latest cash dividend, cementing a tradition that's been rolling since 1935. They're dropping $0.33 per share on the common stock and $0.31 on the Class A common stock. It's set to hit investors' pockets by December 9,...

Continue Reading
Koppers Faces Investigation: Investors Cautious Amid Probe

Updated Category News Views 128

Deep Dive: Koppers' Financial Turmoil When a company throws a financial party, you don't expect the hangover to come in the form of an investigation notice. That’s what’s brewing over at Koppers Holdings Inc., leading many seasoned investors to take a hard, scrutinizing look at the books. The latest buzz? An inquiry into whether the company gave its investors the full...

Continue Reading
Tenax Therapeutics Faces Legal Heat After Stock Plunge

Updated Category News Views 92

Investors' Nerves Tested as Tenax Takes a Nosedive Holy smokes! When a biotech company like Tenax Therapeutics, Inc. (NASDAQ: TENX) detonates like a forgotten fireworks stash, investors have every right to get itchy. Tenax’s shocking announcement that their Phase 3 LEVEL trial for TNX-103 flopped has sparked more than just shareholder anxiety. It’s ignited a...

Continue Reading
Koppers Navigates Q3: Margins Squeeze Amid Growth

Updated Category News Views 110

Investing in Koppers: A Mixed Bag in Q3 Well, it appears Koppers (NYSE: KOP) is doing a bit of a dance this quarter—some smooth steps, but a few stumbles in the rhythm when it comes to margins. The hardwood numbers tell an interesting tale, so let's break it down. Sales Edge Up, But Margins Suffer Koppers clocked in net sales of $499.1 million for the third quarter of...

Continue Reading
Encompass Health Faces Uncertain Future with Sea Pines

Updated Category News Views 119

Unexpected Downpour Closes Sea Pines They say when it rains, it pours. That's not just true in life, but as it happens, it's quite literal in Melbourne, Florida. A deluge of biblical proportions forced an immediate lockdown of the Sea Pines Rehabilitation Hospital. Flooded to the gills, this once stalwart institution finds its doors shuttered indefinitely. It's a...

Continue Reading
Clean Energy: How COP31 Can Change the Future

Updated Category News Views 141

Global Warming: A Battle Heating Up Fast It's like trying to run uphill while carrying the baggage of outdated promises. We’ve got business bigwigs rallying at COP31, demanding the world to get serious about clean energy. If they don’t, we're looking at warming rocketing up to 2.6°C come year 2100. Who's listening though? The Call for Clean Electrification This mob,...

Continue Reading

Top 5 Most Recently Viewed Articles

Growing Demand in Pharmaceutical Excipients Market by 2031

Updated Category News Views 182

Let’s cut to the chase—the pharmaceutical excipients market is heating up. It's not just a smattering of growth here and there; we’re talking about a projected value that’s set to smash through USD 17.13 billion by 2031. That’s a juicy compound annual growth rate (CAGR) of 6.8% from 2024 to 2031 according to SkyQuest Technology. Why the Surge? What's fueling...

Continue Reading
Natural Retreats Enhances Guest Experience with Track Software

Updated Category News Views 354

Natural Retreats Elevates Guest Experience with New Tech Natural Retreats, a leader in the luxury vacation rental market, is making waves with its recent partnership with Track Hospitality Software. This collaboration marks a pivotal shift in how the company operates, ensuring that customer service reaches new heights. By adopting Track's cloud-based property management...

Continue Reading
Lower Factory Input Prices Signal Inflation Relief

Updated Category Economy Views 323

U.S. Manufacturing Sector Contracts for Third Consecutive Month June's U.S. manufacturing sector contracted for the third month running. From 48.7 in May, the Institute for Supply Management (ISM) recorded that its manufacturing PMI dropped to 48.5 in June. A PMI reading less than fifty suggests contraction. Ten percent or so of the U.S. economy is manufacturing....

Continue Reading
Investors Brace for Talen Energy's Earning Report This Week

Updated Category News Views 159

Talen Energy: Prepping for the Earnings Showdown Pencil this one in: February 26, 2026. That’s the big day when Talen Energy (NASDAQ:TLN) rolls out its quarterly earnings report. Investors are chomping at the bit, as EPS is projected to hit a solid $3.68. Get your game faces on folks, because this one could shake up sentiment across the board. The Whisperer’s Corner:...

Continue Reading
Legal Insights: Sage Therapeutics Under Investigation for Alleged Misconduct

Updated Category News Views 119

Understanding the Investigation Surrounding Sage Therapeutics The legal world is buzzing with developments concerning Sage Therapeutics, Inc. (NASDAQ: SAGE), a prominent name in the pharmaceutical industry. Recently, Faruqi & Faruqi, LLP—a respected national securities law firm—has ramped up efforts to investigate potential claims on behalf of investors interested in...

Continue Reading